Procyon Corporation Overview
Pro stress-test →Procyon Corporation is a holding company for its subsidiary AMERX Health Care Corporation, which develops and markets advanced proprietary skin and wound care products used in the treatment of wounds, ulcers, burns, surgical incisions, cuts, scrapes, abrasions, dermatitis, inflammation and other skin problems. The company sells its products to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, physicians, and other health care practitioners.
Strategic Profile
Pro stress-test →AMERX provides skin and wound care products through its proprietary brands, AMERIGEL® Advanced Skin and Wound Care, HELIX3® Bioactive Collagen, and EXTREMIT-EASE®. As of May 2026, the stock price is $0.20 with a market capitalization of $1.64M. The company operates as a micro-cap OTC-traded medical device manufacturer serving the specialized wound and skin care market.
Competitive Landscape
Pro stress-test →Procyon competes in the specialized wound and skin care market against larger medical device manufacturers. Direct competitors include Smith & Nephew (SNWN, NASDAQ), Molnlycke Health Care, and various collagen/dressing manufacturers. Procyon's niche positioning in proprietary hydrogel and collagen products differentiates it from commodity wound dressing suppliers, though its micro-cap scale limits resources for marketing and R&D.
Industry Context
Procyon Corporation operates in Specialty medical device wound care.
Key facts
Founded: 1987 · Headquarters: Oldsmar, FL, United States · Revenue: $4.98M (trailing twelve months as of May 2026) · Market cap: $1.64M (as of May 2026)